Stephen M Stahl MD
Psychopharmacology
Adjunct Professor of Psychiatry University of California San Diego
Join to View Full Profile
1930 Palomar Point WaySte 103Carlsbad, CA 92008
Phone+1 760-444-9065
Fax+1 760-931-8857
Dr. Stahl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1979 - 1981
University of California (San Francisco)Residency, Neurology, 1977 - 1978
University of ChicagoInternship, Internal Medicine, 1976 - 1977
Northwestern University The Feinberg School of MedicineClass of 1974
Certifications & Licensure
OH State Medical License 1975 - 2026
CA State Medical License 1977 - 2025
IN State Medical License 1975 - 2025
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Management of Parkinson's disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switching.Stuart H Isaacson, Henry Nasrallah, Rajesh Pahwa, Gustavo Alva, Daniel Kremens
Expert Opinion on Pharmacotherapy. 2025-04-01 - 1 citationsThe effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation, and plasticity (Neuro-GDP): ...Roger S McIntyre, Natalie Rasgon, Joseph Goldberg, Sabrina Wong, Gia Han Le
CNS Spectrums. 2025-02-18 - Lumateperone for the Treatment of Major Depressive Disorder With Mixed Features or Bipolar Depression With Mixed Features: A Randomized Placebo-Controlled Trial.Suresh Durgam, Susan G Kozauer, Willie R Earley, Changzheng Chen, Jason Huo
Journal of Clinical Psychopharmacology. 2025-02-14
Press Mentions
Genomind Mental Health Map: First-Ever Consumer DNA Test to Unlock the Connection Between Genetics and Mental Wellness-Related Behavioral Tendencies, Offers “How-To” Guidance to Improve Mental Health and WellnessJune 24th, 2020
Researchers Present New Data on the Utility of Genomind's Mental Health Pharmacogenomic Testing at Upcoming Scientific ConferencesSeptember 16th, 2019
FDA Expands Use of Cariprazine to Include Treatment of Depressive EpisodesMay 28th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
